ArticleOncology letters2017

Effects of programmed death-ligand 1 expression on OK-432 immunotherapy following transurethral resection in non-muscle invasive bladder cancer.

Zhi-Hua Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.